Taiwan Industry Reports
Industry Type:   Title:  

 
Biopharmaceutical Manufacturing
2025-MayDoc　#42255Industry Report (condensed version)US$300
The launch of certain Taiwanese-developed biological and biosimilar drugs in the U.S. market has faced delays, primarily due to reduced staffing at pharmaceutical regulatory agencies under the Trump administration. This, combined with persistent weakness in China's self-funded vaccine market, has intensified pressure on Taiwanese manufacturers seeking to expand their U.S. market presence. Nevertheless, overseas sales are expected to remain supported by the continued performance of domestically developed, special-indication biological drugs—such as PharmaEssentia Corporation’s Ropeg and Tanvex BioPharma Inc’s Nypozi—which have already entered international markets. Additionally, Taiwan’s public vaccine procurement volume is projected to rise in 2025 compared to 2024, further supporting domestic demand.
Biotechnology Services
2025-JanDoc　#41539Industry Report (condensed version)US$300
Government-backed initiatives to support the biomedical sector, coupled with enhanced regulatory compliance and the return of domestic medical capacity to pre-pandemic levels, are poised to optimize the operations of local clinical and preclinical CRO and CDMO firms. These favorable conditions are expected to propel continued growth in Taiwan's biotechnology services industry in 2025.
Agricultural Biotechnology lndustry
2024-NovDoc　#41173Industry Report (condensed version)US$300
The agricultural biotechnology industry’s output value is expected to remain on a downward trend in Q4 2024, though the rate of decline is anticipated to moderate.
Wind Power
2024-JunDoc　#40498Industry Report (condensed version)US$300
The annual growth rate of the industry's production value in 2024 is expected to be smaller than in 2023. However, the overall prosperity and development of the industry will continue to maintain a positive trend.
China's Traditional Chinese Medicine Industry-Brief Report
2024-JunDoc　#C_7043Industry Report (condensed version)US$350
With the growing acceptance of specialty Chinese herbal medicines and their products both domestically and internationally, it is expected that China's traditional Chinese medicine manufacturing industry will resume growth in the second half of 2024.
Traditional Chinese Medicine
2024-AprDoc　#40060Industry Report (condensed version)US$300
Given the elevated starting point from the preceding period, the industry landscape is poised to exhibit a degree of stagnation throughout the initial half of 2024.
Biotechnology Services
2024-MarDoc　#39854Industry Report (condensed version)US$300
In 2024, Taiwan's biotechnology service industry is poised to navigate through a landscape marked by both challenges and opportunities. Fierce competition from established players in South Korea and China, delays in the clinical trial process for new drugs both domestically and abroad, and the high costs associated with obtaining key raw materials for manufacturing, suggest the industry's growth momentum may experience pressure.
Food Biotechnology Industry
2024-MarDoc　#39780Industry Report (condensed version)US$300
The industry is poised to rebound and return to a trajectory of stable growth in the first half of 2024.
Regenerative Medicine
2024-FebDoc　#39781Industry Report (condensed version)US$300
Despite the current challenges facing the launch of local cell therapy products in Taiwan and the intense competition faced by surgical suture materials from Chinese players in overseas markets, the domestic market for high-end tissue engineering biomedical material application products remains promising. This is largely due to concerted efforts by domestic players to consolidate and expand markets in China, ASEAN, and emerging markets such as the Middle East and Eastern Europe.
Agricultural Biotechnology
2024-JanDoc　#39507Industry Report (condensed version)US$300
Taiwan's agricultural biotechnology industry is forecast to exhibit stable and sustained growth throughout the year 2024.
 First  Previous  Next  Last  In  1  /  8  Page  (Find  72  records)
 





Copyright (c) 2018 All Rights Reserved by
Taiwan Institute of Economic Research
Taiwan Industry Economics Services
Address: 4Fl., 16-8, Tehui St., Taipei, Taiwan
TEL: 886-2-25865000 ext469; FAX: 886-2-25935543